Navin Fluorine International Limited Board Approves Unaudited Financial Results for Q3 FY2026

Navin Fluorine International Limited (NFIL) announced the approval of its Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. The Board met on February 9, 2026, to adopt the results, which were subjected to a Limited Review. Key highlights include a consolidated revenue of ₹907.95 crore for the quarter and a consolidated Profit After Tax of ₹185.40 crore.

Quarterly Financial Results Approval

The Board of Directors of Navin Fluorine International Limited met on February 9, 2026, and approved the Unaudited Standalone and Consolidated Financial Results for the period ended December 31, 2025. The results cover both the third quarter and the nine-month period of the fiscal year.

Consolidated Performance Highlights (Annexure A)

The consolidated results for the quarter ended December 31, 2025, showed robust performance:

  • Total Revenue (a+b): Reported at ₹907.95 crore, compared to ₹776.63 crore in the previous quarter (Sep 30, 2025).
  • Profit Before Tax: Stood at ₹238.26 crore.
  • Profit After Tax (PAT): Reached ₹185.40 crore.
  • Total Comprehensive Income: Recorded at ₹186.40 crore for the period.

For the Nine Months Ended December 31, 2025, consolidated Total Revenue was ₹2,423.89 crore, and the resulting PAT was ₹450.94 crore.

Standalone Performance Highlights (Annexure B)

The standalone financial results also demonstrated growth:

  • Total Revenue (a+b) for the Quarter: Stood at ₹589.88 crore.
  • Profit Before Tax for the Quarter: Registered at ₹140.59 crore.
  • Profit After Tax (PAT) for the Quarter: Amounted to ₹105.87 crore.
  • Total Comprehensive Income for the Quarter: Was ₹106.65 crore.

For the Nine Months Ended December 31, 2025, standalone PAT was ₹352.64 crore.

Key Notes and Exceptional Items

Several significant events impacted the quarter’s results, as detailed in the notes:

  • The company paid an interim dividend of ₹6.50 per share (325%) aggregating to ₹33.31 crores for FY 2025-26 during the quarter.
  • A substantial fund-raising exercise through Qualified Institutional Placement (QIP) was approved in July 2025, resulting in the allotment of 16,02,564 Equity Shares at an issue price of ₹4,680.00 per Share, aggregating approximately ₹750 crores.
  • An Exceptional Item was recognized related to the reassessment of employee benefit obligations following the implementation of the ‘New Labour Codes’ effective November 21, 2025. This resulted in an incremental liability of ₹20.47 crores (Consolidated) and ₹18.84 crores (Standalone), recognized as an expense.
  • The Group continues to operate in a single reportable segment: ‘Chemical Business’.

Auditor’s Review Conclusion

Price Waterhouse Chartered Accountants LLP, the statutory auditors, confirmed that based on their review, nothing has come to their attention to suggest that the accompanying statements are not prepared in all material respects in accordance with applicable standards and regulations. However, the conclusion on the Consolidated Results was not modified despite the interim financial results of certain subsidiaries and the joint venture (which have not been fully reviewed by their respective auditors) not being material to the Group.

Source: BSE

Previous Article

RattanIndia Enterprises Board Meeting Scheduled for February 12, 2026, to Approve Q3 FY2026 Results

Next Article

Intellect Design Arena Ltd DUCA Credit Union Selects eMACH.ai DEP for Digital Banking Transformation in Canada